KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 70 filers reported holding KALA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $29,000 | -6.5% | 21,331 | -18.0% | 0.00% | – |
Q4 2021 | $31,000 | -80.7% | 26,020 | -57.6% | 0.00% | – |
Q3 2021 | $161,000 | -54.4% | 61,386 | -7.8% | 0.00% | – |
Q2 2021 | $353,000 | -12.2% | 66,592 | +11.6% | 0.00% | -100.0% |
Q1 2021 | $402,000 | -0.7% | 59,677 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $405,000 | -9.6% | 59,677 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $448,000 | -28.5% | 59,677 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $627,000 | +97.8% | 59,677 | +65.5% | 0.00% | 0.0% |
Q1 2020 | $317,000 | +155.6% | 36,054 | +7.2% | 0.00% | – |
Q4 2019 | $124,000 | -3.1% | 33,623 | 0.0% | 0.00% | – |
Q3 2019 | $128,000 | -40.5% | 33,623 | 0.0% | 0.00% | – |
Q2 2019 | $215,000 | +4.9% | 33,623 | +35.4% | 0.00% | – |
Q1 2019 | $205,000 | +81.4% | 24,831 | +7.2% | 0.00% | – |
Q4 2018 | $113,000 | -35.8% | 23,158 | +30.0% | 0.00% | – |
Q3 2018 | $176,000 | -28.2% | 17,816 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $245,000 | -28.8% | 17,816 | -18.0% | 0.00% | 0.0% |
Q1 2018 | $344,000 | +47.0% | 21,726 | +71.5% | 0.00% | – |
Q4 2017 | $234,000 | -22.3% | 12,671 | -4.0% | 0.00% | -100.0% |
Q3 2017 | $301,000 | – | 13,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 1 | $9 | 0.00% |